Table 2.
Variable | Patients, n | Recurrence, n (%) | P-value | Survival, months, median (range) | P-value |
---|---|---|---|---|---|
Age >65 years | 5 | 3 (60%) | 0.2 | 10 (6–55) | 0.8 |
Age ≤65 years | 19 | 6 (31%) | 42 (6–132) | ||
Positive lymph nodes | 3 | 3 (100%) | 0.01 | 10 (10–15) | 0.2 |
Negatives lymph nodes | 21 | 6 (28%) | 42 (6–132) | ||
Vascular invasion present | 2 | 2 (100%) | 0.05 | 11 (10–12) | 0.05 |
Vascular invasion absent | 22 | 7 (32%) | 31 (6–132) | ||
R0 resection | 23 | 8 (35%) | 0.1 | 31 (6–132) | 0.4 |
R1 resection | 1 | 1 (100%) | 12 | ||
T-stage | |||||
Ib | 1 | 0 | 0.01 | 6 | 0.001 |
II | 10 | 1 (10%) | 65 (15–132) | ||
III | 12 | 8 (66%) | 10 (6–84) | ||
Tumour–node–metastasis (TNM) stage | |||||
I | 1 | 0 | 0.006 | 6 | 0.003 |
II | 10 | 0 | 65 (31–132) | ||
IIIa | 9 | 5 (55%) | 12 (6–84) | ||
IIIb | 2 | 2 (100%) | 14.5 (10–15) | ||
IVb | 2 | 2 (100%) | 8 (6–10) | ||
Residual disease present | 10 | 10 (100%) | 0.001 | 10 (6–15) | <0.001 |
Residual disease absent | 14 | 0 | 65 (6–132) |